Why Do People Have Beauty Marks? The Causes & Meaning

Beauty marks are small clusters of pigment-producing skin cells called melanocytes that have gathered in one spot instead of spreading evenly across the skin. Nearly every adult has at least a few, and most people develop between ten and forty over a lifetime. The biology behind them involves a surprisingly complex interplay of embryonic development, genetics, sun exposure, and a built-in cellular brake system that keeps most moles from ever becoming dangerous. What culture calls a “beauty mark” and what dermatology calls a melanocytic nevus are the same thing, and the science behind them is more interesting than the name suggests.

Where Melanocytes Come From

Every mole on your body traces back to a type of cell that starts its life nowhere near the skin. Melanocytes originate from a structure called the neural crest, a temporary band of cells in the developing embryo. During the first weeks of fetal growth, these precursor cells migrate outward from the neural crest, traveling through the embryo to reach specific locations in the skin and hair follicles.¹ Think of it as a long commute: cells that will eventually produce pigment have to journey from deep inside the embryo to the surface of the body.

Once melanocytes arrive in the skin, they normally space themselves out fairly evenly, each one producing melanin pigment and distributing it to surrounding skin cells. A mole forms when a group of melanocytes clusters together in one location instead of spreading apart. This clustering can happen before birth, producing what are called congenital moles, or it can occur during childhood, adolescence, or adulthood, producing acquired moles. The distinction between the two is not always clear-cut under a microscope: some acquired moles that develop in early childhood can display structural features once thought to be unique to congenital ones.²

The Built-In Brake System

One of the more fascinating aspects of moles is that many of them contain a genetic mutation that, in theory, should drive the cells to keep multiplying. A large proportion of common moles carry a mutation in a gene called BRAF, the same mutation found in about half of all melanomas. So why don’t most moles become cancer?

The prevailing explanation for decades has been a process called oncogene-induced senescence. When the BRAF mutation activates in a melanocyte, it initially pushes the cell to divide. But the cell recognizes this as a danger signal and triggers an internal shutdown program: it stops dividing and enters a dormant state. Research has shown that when the BRAF mutation is sustained in human melanocytes, the cells halt their cycle and display markers associated with this dormant state.³ In a sense, a mole is a tiny tumor that policed itself before it could become a problem. The BRAF mutation gets the cells growing, and the senescence program stops them.

This explains why a person can carry dozens of moles for a lifetime without any trouble: each mole is a colony of cells that hit the brakes. For a mole to become melanoma, additional safeguards have to fail. Research has found that inactivation of further tumor-suppressor pathways is needed on top of the BRAF mutation for a melanocyte to break through senescence and keep dividing.⁴ This multi-layered defense is why the vast majority of moles remain harmless.

The senescence theory is not entirely settled, though. A mouse study that tracked mole cell behavior and gene expression found no clear evidence that mole cells were senescent compared to other melanocytes or skin cells, suggesting the growth arrest might work through a different or more nuanced mechanism than classic senescence.⁵ The bottom line for you: something reliably stops most moles from growing, even if scientists are still debating exactly what that something is.

Genetics and Why Some People Have More Moles

If you’ve noticed that mole-heavy skin tends to run in families, you’re not imagining it. Twin studies and genome-wide scans have identified several chromosomal regions linked to mole count. One of the strongest signals maps to a region on chromosome 9 near the CDKN2A gene, which is also a known melanoma susceptibility gene.⁶ Additional linkage signals have been found on chromosomes 2, 8, 17, and others, suggesting that mole count is influenced by many genes acting together rather than a single inherited switch.

Variants in the MC1R gene, best known for its role in red hair and fair skin, also influence the number and distribution of moles. Studies of adolescent twins found relationships between MC1R variants and both freckling tendency and mole count.⁷ People with fair skin, light eyes, and a tendency to freckle tend to develop more moles on average, and much of this clustering of traits traces back to the same group of pigmentation genes.

So your total mole count is partly a genetic hand you were dealt. But genes only set the stage. The environment fills in the details.

Sun Exposure and the Making of New Moles

If genetics loads the gun, ultraviolet radiation pulls the trigger. Sunlight is the strongest environmental driver of new mole formation, especially during childhood. A large cross-sectional study of British children found that a propensity to burn rather than tan, a history of sunburn, a tendency to freckle, and increased sun exposure were all associated with having more moles. There was a striking association between mole count and the number of foreign holidays in a hot climate, and this held up even after accounting for whether the child had actually been sunburned.⁸

Childhood sun exposure appears to matter more than adult exposure. A population-based study found that people who experienced four or more severe sunburns during childhood had roughly three times the odds of having a high mole count compared to those who had none, and this association held even after adjusting for skin sensitivity and sunburns at other ages.⁹ The implication is that the melanocytes in young skin are more susceptible to UV-triggered mutation and clustering.

This connection works in the other direction, too. A randomized controlled trial in North Queensland tested whether dressing young children in sun-protective clothing could reduce new mole formation. Children who regularly wore UPF 30-50+ clothing covering about half their body developed roughly a quarter fewer new moles overall after three and a half years compared to children in the control group.¹⁰ Fewer moles on clothing-covered skin specifically confirmed that the protection was local, not just a general effect of being a sun-cautious family.

How Moles Change Over a Lifetime

Moles are not static. Most people develop new ones throughout childhood and into early adulthood, with mole counts typically peaking somewhere between ages twenty and forty. After that, moles tend to slowly fade, flatten, or disappear entirely. By old age, many people have noticeably fewer moles than they did in their thirties.

One visible example of this natural regression is the halo nevus, where a ring of lighter skin appears around a mole before the mole gradually vanishes. This happens when the immune system targets the pigmented cells, and lymphocytes and other immune cells infiltrate the mole and break it down from the inside.¹¹ Halo nevi are most common in teenagers and young adults and are almost always harmless, though a dermatologist may want to check one to be safe.

Hormonal shifts can also affect moles. During pregnancy, there’s a long-standing belief that moles darken or grow. The reality is more modest: one study tracking moles during pregnancy found that only about six percent changed in diameter, and the changes were tiny, with some growing by a millimeter and others shrinking by the same amount. Hormones may subtly influence mole appearance, but the effect is far smaller than commonly assumed.

When Moles Deserve Attention

The overwhelming majority of moles are harmless and stay that way. But because melanoma can arise from a pre-existing mole or mimic one, knowing when to be concerned matters. The standard clinical tool is the ABCDE checklist: asymmetry, border irregularity, color variation, diameter larger than about six millimeters, and evolution or change over time. Any mole that changes rapidly, bleeds without being scratched, or looks different from your other moles warrants a visit to a dermatologist.

Having a lot of moles is itself a risk factor. A case-control study found that people with a hundred or more moles of at least two millimeters had nearly eight times the odds of developing melanoma compared to those with very few moles.¹² This doesn’t mean every mole-heavy person will develop melanoma. Most won’t. But it does mean that people with many moles benefit from routine skin checks.

Atypical moles, sometimes called dysplastic nevi, sit in an awkward gray zone. They’re larger than typical moles, may have uneven borders or mixed coloring, and under a microscope they show cellular features that are neither clearly normal nor clearly malignant. Pathologists can reliably distinguish severely atypical moles from mild and moderate ones based on nuclear abnormalities, but telling mild from moderate is much harder.¹³ This diagnostic fuzziness means that if your dermatologist biopsies a mole and calls it “mildly atypical,” the clinical significance is genuinely uncertain, and monitoring rather than aggressive treatment is often reasonable.

Unusual Mole Variants

Not all moles look or behave the same. One notable variant is the Spitz nevus, a pink or reddish-brown mole that tends to appear in children and young adults. Spitz nevi were originally called “juvenile melanomas” because they look alarming under the microscope, with large spindled or rounded cells that can mimic cancer. They were later reclassified as benign, though there remains ongoing debate about whether some Spitz-type tumors sit on a spectrum that includes borderline malignant lesions.¹⁴ Recent molecular work has helped clarify which Spitz lesions are truly worrisome, but the diagnosis still requires expert pathology review.

Blue nevi, another variant, appear as small blue-gray dots because their melanocytes sit deeper in the skin, causing the pigment to scatter through the overlying tissue. Dermal melanocytoses, Mongolian spots in newborns, and café-au-lait spots are related phenomena involving pigment cells at different skin depths or densities. Each of these has a distinct biology, even though they all ultimately come from the same melanocyte lineage.

The Psychological Weight of a Visible Mark

The term “beauty mark” itself reveals something about the cultural lens we bring to moles. A small, well-placed dark spot near the lip or cheek has been considered attractive across many eras and cultures. In seventeenth-century France, women applied artificial beauty patches to their faces, with the placement of each dot carrying coded social meaning. The idealization of certain moles as “beauty marks” has persisted in fashion and media to this day.

But this cultural glamor coexists with genuine distress for some people. Research on how facial lesions affect attractiveness judgments found that small marks, whether centrally or peripherally located on the face, did not significantly reduce perceived attractiveness. Larger lesions, however, did lower attractiveness ratings, and the perceived need for “repair” was driven mostly by size rather than location.¹⁵ Interestingly, the study also found that attractiveness and the sense that a lesion was disfiguring were only weakly correlated, suggesting that people can simultaneously find a face attractive and notice a blemish without the two feelings collapsing into one.

At the extreme end, clinicians have identified a pattern called naevus dysmorphia, where a person becomes preoccupied with a small, clinically insignificant mole that they perceive as disfiguring. This preoccupation can lead to social avoidance, anxiety, and low mood. Surgically removing the mole typically does not resolve the underlying distress, because the issue is a body-image problem rather than a dermatological one.¹⁶ Recognizing this pattern matters because it prevents unnecessary procedures and directs people toward more appropriate support.

AI and the Future of Mole Monitoring

If you’ve ever used a phone app that claims to analyze your moles, you’ve encountered the early edge of artificial intelligence in dermatology. The field is evolving quickly. One study developing an AI model for dermoscopy images reported overall accuracy of about 92 percent in distinguishing benign from malignant skin lesions.¹⁷ That sounds impressive, but context matters: dermoscopy images are taken with specialized magnifying equipment, not a phone camera in bathroom lighting.

A more rigorous prospective validation study tested an open-source AI algorithm against real-world dermatologist decisions. At a preset sensitivity threshold of 95 percent, the AI correctly flagged nearly 97 percent of melanomas but had a specificity of only about 37 percent, meaning it called a lot of benign moles suspicious. The valuable finding, though, was that dermatologists who saw the AI’s assessment before making their own call made significantly better decisions than they had without it.¹⁸ The AI worked best as a second opinion for an expert rather than a replacement for one.

For the average person tracking their moles at home, the practical takeaway is that technology can help but isn’t yet reliable enough to replace professional skin exams. Photographing your moles regularly so you can compare them over time remains one of the simplest and most effective self-monitoring strategies. Changes visible to the naked eye over months still matter more than any algorithm score.

Moles and Telomere Length

An intriguing but still-developing line of research has explored whether people with many moles age differently at the cellular level. The theory centers on telomeres, the protective caps at the ends of chromosomes that shorten as cells divide. Some earlier observational work suggested that mole-heavy individuals might have longer telomeres on average, which would imply that their cells retain more replicative capacity. The connection to the BRAF-driven growth arrest discussed earlier is tantalizing: if mole cells avoid telomere shortening as part of their senescence-like halt, and if the genes influencing mole count overlap with genes influencing telomere biology, the two traits might share a deeper link.

However, a study examining telomere length in skin cancer cases and controls found a more complicated picture. Among controls, few of the traditional skin-cancer risk factors were clearly associated with telomere length. And among melanoma cases specifically, older age at blood draw was associated with longer telomeres, which runs counter to the normal pattern of telomere shortening with age.¹⁹ This is the kind of finding that researchers call “hypothesis-generating” rather than conclusive. The relationship between moles, telomere biology, and aging is real enough to study but far too early to build any practical advice around.